State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$2.01B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Apple
AAPL
|
+$1.06B |
| 5 |
Amazon
AMZN
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.87B |
| 2 |
ExxonMobil
XOM
|
+$656M |
| 3 |
Chevron
CVX
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$569M |
| 5 |
X
US Steel
X
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.32% |
| 2 | Financials | 14.17% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Healthcare | 9.66% |
| 5 | Industrials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
SCYNEXIS
SCYX
$37.4M
| $81.5K | ﹤0.01% |
15,091
| – | – |
|
|
CIRC
3827
Circle8 Group
CIRC
$63.9M
| $81.4K | ﹤0.01% |
+40,119
| New | +$121K |
|
3828
Acrivon Therapeutics
ACRV
$61.2M
| $79.9K | ﹤0.01% |
67,145
-165,406
| -71% | -$227K |
|
3829
Prelude Therapeutics
PRLD
$375M
| $79K | ﹤0.01% |
97,592
-188,454
| -66% | -$163K |
|
|
QVCGA
3830
DELISTED
QVC Group Inc Series A
QVCGA
| $77.6K | ﹤0.01% |
28,233
-5
| -0% | -$29 |
|
3831
Telomir Pharmaceuticals
TELO
$83.2M
| $77K | ﹤0.01% |
61,600
-64,073
| -51% | -$148K |
|
3832
PepGen
PEPG
$118M
| $76.7K | ﹤0.01% |
69,140
-250,963
| -78% | -$355K |
|
3833
Armata Pharmaceuticals
ARMP
$168M
| $76.6K | ﹤0.01% |
40,300
| – | – |
|
|
LPA
3834
Logistic Properties of the Americas
LPA
$91.7M
| $76.5K | ﹤0.01% |
+11,200
| New | +$79.3K |
|
3835
RAVE Restaurant Group
RAVE
$42.8M
| $76K | ﹤0.01% |
27,641
| – | – |
|
|
NIXX
3836
Nixxy Inc
NIXX
$18.6M
| $75.9K | ﹤0.01% |
36,331
| – | – |
|
3837
374Water
SCWO
$37.4M
| $75.2K | ﹤0.01% |
23,176
-73,407
| -76% | -$247K |
|
3838
Ovid Therapeutics
OVID
$427M
| $74.9K | ﹤0.01% |
227,033
-1,145,075
| -83% | -$345K |
|
3839
Harte-Hanks
HHS
$16.4M
| $74.8K | ﹤0.01% |
18,797
| – | – |
|
3840
Lantern Pharma
LTRN
$32M
| $74.7K | ﹤0.01% |
23,652
| – | – |
|
3841
Modular Medical
MODD
$11.3M
| $74.6K | ﹤0.01% |
3,337
| – | – |
|
|
KYNB
3842
Kyntra Bio
KYNB
$27.4M
| $72.7K | ﹤0.01% |
13,719
-3
| -0% | -$22 |
|
3843
Beam Global
BEEM
$21.7M
| $72.3K | ﹤0.01% |
49,528
| – | – |
|
3844
BTCS Inc
BTCS
$49.3M
| $71.9K | ﹤0.01% |
32,700
| – | – |
|
3845
FibroBiologics
FBLG
$3.98M
| $71.9K | ﹤0.01% |
5,775
-22,548
| -80% | -$407K |
|
|
ELEV
3846
DELISTED
Elevation Oncology
ELEV
| $71.5K | ﹤0.01% |
194,800
-861,517
| -82% | -$288K |
|
|
DRRX
3847
DELISTED
DURECT Corp
DRRX
| $71.4K | ﹤0.01% |
112,384
| – | – |
|
3848
Century Therapeutics
IPSC
$364M
| $71.2K | ﹤0.01% |
127,443
-718,778
| -85% | -$386K |
|
3849
Franklin Wireless
FKWL
$27.2M
| $70.6K | ﹤0.01% |
16,900
| – | – |
|
3850
Scilex Holding
SCLX
$46.1M
| $70K | ﹤0.01% |
11,888
-204,981
| -95% | -$1.16M |
|
Similar funds
State Street's Q2 2025 Portfolio in Review
As of Q2 2025, State Street held 4,369 positions worth $2.67T, up 9.9% from $2.43T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.5%. State Street opened 86 new positions and exited 109, leaving the 4,369-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- State Street's largest Q2 2025 buy was Ralliant Corp: 4,394,640 shares worth $213M.
- State Street added most to Capital One in Q2 2025, an estimated $2.01B increase.
- State Street's biggest Q2 2025 reduction was ExxonMobil, cutting an estimated $656M.
- State Street fully exited Discover Financial Services in Q2 2025, selling an estimated $1.87B.
- State Street's ten largest holdings make up 29% of its $2.67T portfolio in Q2 2025.
- State Street opened 86 new positions and closed 109 in Q2 2025.
- State Street's portfolio value rose 9.9% quarter-over-quarter to $2.67T.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.